AAAAAA

   
Results: 1-20 |
Results: 20
Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon
Authors: Rosenberg, JJ Martin, SW Seely, JE Kinstler, O Gaines, GC Fukuzuka, K Rose, J Kohno, T Boyle, WJ Nelson, A Kieft, GL Marshall, WS Feige, U Gasser, J St Clair, J Frazier, J Abouhamze, A Moldawer, LL Edwards, CK
Citation: Jj. Rosenberg et al., Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon, J APP PHYSL, 91(5), 2001, pp. 2213-2223
Regulation of osteoclastogenesis and RANK expression by TGF-beta 1
Authors: Yan, T Riggs, BL Boyle, WJ Khosla, S
Citation: T. Yan et al., Regulation of osteoclastogenesis and RANK expression by TGF-beta 1, J CELL BIOC, 83(2), 2001, pp. 320-325
Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption
Authors: Riggs, L Baron, R Boyle, WJ Drezner, M Manolagas, S Martin, TJ Stewart, AF Suda, T Yasuda, H Aubin, J Goltzman, D
Citation: L. Riggs et al., Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption, BONE, 27(6), 2000, pp. 761-764
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity
Authors: Yu, G Boone, T Delaney, J Hawkins, N Kelley, M Ramakrishnan, M McCabe, S Qiu, W Kornuc, M Xia, XZ Guo, J Stolina, M Boyle, WJ Sarosi, I Hsu, HL Senaldi, G Theill, LE
Citation: G. Yu et al., APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity, NAT IMMUNOL, 1(3), 2000, pp. 252-256
Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption
Authors: Riggs, BL Baron, R Boyle, WJ Drezner, M Manolagas, S Martin, TJ Stewart, AF Suda, T Yasuda, H Aubin, J Goltzman, D
Citation: Bl. Riggs et al., Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption, J BONE MIN, 15(12), 2000, pp. 2293-2296
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
Authors: Hofbauer, LC Khosla, S Dunstan, CR Lacey, DL Boyle, WJ Riggs, BL
Citation: Lc. Hofbauer et al., The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption, J BONE MIN, 15(1), 2000, pp. 2-12
Osteoprotegerin ligand: a regulator of immune responses and bone physiology
Authors: Kong, YY Boyle, WJ Penninger, JM
Citation: Yy. Kong et al., Osteoprotegerin ligand: a regulator of immune responses and bone physiology, IMMUNOL TOD, 21(10), 2000, pp. 495-502
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development
Authors: Fata, JE Kong, YY Li, J Sasaki, T Irie-Sasaki, J Moorehead, RA Elliott, R Scully, S Voura, EB Lacey, DL Boyle, WJ Khokha, R Penninger, JM
Citation: Je. Fata et al., The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development, CELL, 103(1), 2000, pp. 41-50
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice
Authors: Khare, SD Sarosi, I Xia, XZ McCabe, S Miner, K Solovyev, I Hawkins, N Kelley, M Chang, D Van, G Ross, L Delaney, J Wang, L Lacey, D Boyle, WJ Hsu, HL
Citation: Sd. Khare et al., Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice, P NAS US, 97(7), 2000, pp. 3370-3375
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
Authors: Li, J Sarosi, I Yan, XQ Morony, S Capparelli, C Tan, HL McCabe, S Elliott, R Scully, S Van, G Kaufman, S Juan, SC Sun, Y Tarpley, J Martin, L Christensen, K McCabe, J Kostenuik, P Hsu, H Fletcher, F Dunstan, CR Lacey, DL Boyle, WJ
Citation: J. Li et al., RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism, P NAS US, 97(4), 2000, pp. 1566-1571
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation
Authors: Xia, XZ Treanor, J Senaldi, G Khare, SD Boone, T Kelley, M Theill, LE Colombero, A Solovyev, I Lee, F McCabe, S Elliott, R Miner, K Hawkins, N Guo, J Stolina, M Yu, G Wang, J Delaney, J Meng, SY Boyle, WJ Hsu, HL
Citation: Xz. Xia et al., TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation, J EXP MED, 192(1), 2000, pp. 137-143
Characterization of osteoclast precursors in human blood
Authors: Shalhoub, V Elliott, G Chiu, L Manoukian, R Kelley, M Hawkins, N Davy, E Shimamoto, G Beck, J Kaufman, SA Van, G Scully, S Qi, M Grisanti, M Dunstan, C Boyle, WJ Lacey, DL
Citation: V. Shalhoub et al., Characterization of osteoclast precursors in human blood, BR J HAEM, 111(2), 2000, pp. 501-512
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
Authors: Lacey, DL Tan, HL Lu, J Kaufman, S Van, G Qiu, WR Rattan, A Scully, S Fletcher, F Juan, T Kelley, M Burgess, TL Boyle, WJ Polverino, AJ
Citation: Dl. Lacey et al., Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo, AM J PATH, 157(2), 2000, pp. 435-448
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Authors: Lomaga, MA Yeh, WC Sarosi, I Duncan, GS Furlonger, C Ho, A Morony, S Capparelli, C Van, G Kaufman, S van der Heiden, A Itie, A Wakeham, A Khoo, W Sasaki, T Cao, ZD Penninger, JM Paige, CJ Lacey, DL Dunstan, CR Boyle, WJ Goeddel, DV Mak, TW
Citation: Ma. Lomaga et al., TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling, GENE DEV, 13(8), 1999, pp. 1015-1024
Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development
Authors: Kong, YY Boyle, WJ Penninger, JM
Citation: Yy. Kong et al., Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development, IMM CELL B, 77(2), 1999, pp. 188-193
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formationfrom human peripheral blood mononuclear cell precursors
Authors: Shalhoub, V Faust, J Boyle, WJ Dunstan, CR Kelley, M Kaufman, S Scully, S Van, G Lacey, DL
Citation: V. Shalhoub et al., Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formationfrom human peripheral blood mononuclear cell precursors, J CELL BIOC, 72(2), 1999, pp. 251-261
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Authors: Kong, YY Feige, U Sarosi, I Bolon, B Tafuri, A Morony, S Capparelli, C Li, J Elliott, R McCabe, S Wong, T Campagnuolo, G Moran, E Bogoch, ER Van, G Nguyen, LT Ohashi, PS Lacey, DL Fish, E Boyle, WJ Penninger, JM
Citation: Yy. Kong et al., Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, NATURE, 402(6759), 1999, pp. 304-309
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Authors: Kong, YY Yoshida, H Sarosi, I Tan, HL Timms, E Capparelli, C Morony, S Oliveira-dos-Santos, AJ Van, G Itie, A Khoo, W Wakeham, A Dunstan, CR Lacey, DL Mak, TW Boyle, WJ Penninger, JM
Citation: Yy. Kong et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, NATURE, 397(6717), 1999, pp. 315-323
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
Authors: Hsu, HL Lacey, DL Dunstan, CR Solovyev, I Colombero, A Timms, E Tan, HL Elliott, G Kelley, MJ Sarosi, I Wang, L Xia, XZ Elliott, R Chiu, L Black, T Scully, S Capparelli, C Morony, S Shimamoto, G Bass, MB Boyle, WJ
Citation: Hl. Hsu et al., Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand, P NAS US, 96(7), 1999, pp. 3540-3545
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
Authors: Burgess, TL Qian, YX Kaufman, S Ring, BD Van, G Capparelli, C Kelley, M Hsu, HL Boyle, WJ Dunstan, CR Hu, S Lacey, DL
Citation: Tl. Burgess et al., The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts, J CELL BIOL, 145(3), 1999, pp. 527-538
Risultati: 1-20 |